David J Conn

Title: David J Conn: Innovator in Antihyperproliferative and Anti-inflammatory Agents

Introduction

David J Conn is a notable inventor based in Somerville, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antihyperproliferative and anti-inflammatory agents. With a total of 2 patents, Conn's work is recognized for its potential impact on skin disease treatments.

Latest Patents

Conn's latest patents include innovative compounds such as substituted-2,3-dihydro-6-substituted-pyrimido[2,1-F]-purine and substituted 2,3-dihydro-6-substituted-pyrimido[2,1-f]purine-4,8(1H, 9H)-diones. These compounds are disclosed for use as antihyperproliferative agents in skin diseases, with methods for their preparation and application described in detail. Additionally, he has developed anti-inflammatory and anti-allergic agents, specifically substituted 2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]purine-4,8(1H,9H)-diones, along with their tautomers and salts.

Career Highlights

David J Conn is associated with Schering Corporation, where he has been instrumental in advancing pharmaceutical research. His work focuses on creating effective treatments for various skin conditions, showcasing his dedication to improving patient outcomes through innovative solutions.

Collaborations

Conn has collaborated with esteemed colleagues such as Daniel M Solomon and James J Kaminski. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.

Conclusion

David J Conn's contributions to the field of pharmaceuticals highlight his role as an inventor dedicated to addressing critical health issues. His innovative patents and collaborations reflect a commitment to advancing medical science and improving the quality of life for patients.